Menassie Taddese
Vermogen: 148 412 $ op 30-09-2026
Vermogen: 148 412 $ op 30-09-2026
Mr. Menassie Taddese is an Independent Director at Medexus Pharmaceuticals, Inc. He is on the Board of Directors at Xeris Biopharma Holdings, Inc. and Medexus Pharmaceuticals, Inc. Mr. Taddese was previously employed as a President-Emerging Markets by Viatris, Inc.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 25-09-2025 | 42.869 ( 0,14% ) | 148 412 $ | 30-09-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Directeur/Bestuurslid | 06-02-2023 |
| XERIS BIOPHARMA HOLDINGS, INC. | Directeur/Bestuurslid | 02-11-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| VIATRIS INC. | Corporate Officer/Principal | 01-12-2022 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
The Pennsylvania State University
The Pennsylvania State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Virginia Polytechnic Institute & State University
Virginia Polytechnic Institute & State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Viatris, Inc.
Viatris, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales pharmaceutical products | Health Technology |
Xeris Biopharma Holdings, Inc.
Xeris Biopharma Holdings, Inc. BiotechnologyHealth Technology Develops and commercializes therapies | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau